Amedisys’ (AMED) “Equal Weight” Rating Reaffirmed at Stephens

Amedisys (NASDAQ:AMED)‘s stock had its “equal weight” rating reissued by research analysts at Stephens in a report issued on Tuesday,Benzinga reports. They presently have a $101.00 price target on the health services provider’s stock. Stephens’ price objective points to a potential upside of 9.78% from the stock’s current price.

Amedisys Stock Performance

Amedisys stock opened at $92.00 on Tuesday. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. The firm has a market capitalization of $3.01 billion, a P/E ratio of 36.51, a price-to-earnings-growth ratio of 1.78 and a beta of 0.73. Amedisys has a 1-year low of $82.15 and a 1-year high of $98.95. The company’s 50-day moving average is $91.55 and its 200 day moving average is $93.10.

Amedisys (NASDAQ:AMED) last issued its quarterly earnings results on Wednesday, February 26th. The health services provider reported $0.96 earnings per share for the quarter, missing the consensus estimate of $1.05 by ($0.09). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business had revenue of $598.05 million during the quarter, compared to analysts’ expectations of $602.38 million. Research analysts forecast that Amedisys will post 4.4 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Blue Trust Inc. lifted its holdings in Amedisys by 55.1% during the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider’s stock valued at $34,000 after buying an additional 124 shares in the last quarter. HBW Advisory Services LLC purchased a new position in shares of Amedisys during the fourth quarter worth approximately $38,000. Versant Capital Management Inc raised its stake in shares of Amedisys by 68.5% during the fourth quarter. Versant Capital Management Inc now owns 450 shares of the health services provider’s stock valued at $41,000 after acquiring an additional 183 shares in the last quarter. Johnson Financial Group Inc. purchased a new stake in shares of Amedisys in the fourth quarter valued at approximately $55,000. Finally, KBC Group NV bought a new position in Amedisys in the third quarter worth approximately $63,000. 94.36% of the stock is currently owned by institutional investors.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.